Results 101 to 110 of about 8,147 (216)

Recurrence patterns following CRS-HIPEC in patients with colorectal peritoneal metastases:Insights from the Dutch CRS-HIPEC registry [PDF]

Introduction: Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is currently the only treatment with curative intent for selected patients with colorectal peritoneal metastases.
Hemmer, P. H. J., De Hingh, I. H. J. T., van Erning, F. N., van den Heuvel, T. B. M., de Reuver, P. R., Wiezer, R. J., Madsen, E. V. E., Witkamp, A. J.   +7 more
core   +1 more source

An update of peritonectomy procedures used in cytoreductive surgery for peritoneal malignancy

International Journal of Hyperthermia, 2019
Background: Complete cytoreduction is acknowledged to be an effective way to achieve macroscopic tumor clearance for a variety of tumors confined to the peritoneal cavity.
Frédéric Mercier, Faheez Mohamed, Jean-Baptiste Cazauran, Vahan Kepenekian, Delphine Vaudoyer, Eddy Cotte, Olivier Glehen, Guillaume Passot   +7 more
doaj   +1 more source

Zdravljenje bolnikov s karcinozo peritoneja s HIPEC: vloga anesteziologa [PDF]

, 2010
The diagnosis of peritoneal carcinomatosis is often associated with poor prognosis and a median survival of a few months, depending on the primary tumor.
Novak, Barbka
core   +1 more source

Can Elderly Patients with Peritoneal Metastasis Induced by Appendiceal or Colorectal Tumours Benefit from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?

Clinical Interventions in Aging, 2021
Sicheng Zhou,1,* Qiang Feng,1,* Jing Zhang,2 Haitao Zhou,1 Zheng Jiang,1 Jianwei Liang,1 Wei Pei,1 Qian Liu,1 Zhixiang Zhou,1 Xishan Wang1 1Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer ...
Zhou S, Feng Q, Zhang J, Zhou H, Jiang Z, Liang J, Pei W, Liu Q, Zhou Z, Wang X   +9 more
doaj  

Lobaplatin in Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer: Safety and Efficacy Profiles

Cancer Management and Research, 2020
Yuxin Zhong,1 Jing Zhang,2 Xiaofeng Bai,1 Yuemin Sun,1 Hao Liu,1 Shuai Ma,1 Yang Li,1 Wenzhe Kang,1 Fuhai Ma,1 Weikun Li,1 Yantao Tian1 1Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer ...
Zhong Y, Zhang J, Bai X, Sun Y, Liu H, Ma S, Li Y, Kang W, Ma F, Li W, Tian Y   +10 more
doaj  

HIPEC Ca Ορθού

, 2021
Globally colorectal cancer is the third most common cancer and ranks as the fourth most common cancer related mortality. The American Cancer Society (ACS) estimates that 97,220 new cases of colon cancer and 43,030 new cases of rectal cancer will occur in 2018; 25,920 cases of rectal cancer are expected in men and 17,110 in women accordingly ...
openaire   +1 more source

Toxicokinetics and toxicodynamics of platinum during the procedure hipec with cisplatin in peritoneal carcinomatosis treatment [PDF]

, 2016
Проведено пилотное исследование токсикокинетики и токсикодинамики при проведении процедуры HIPEC с использованием цисплатина при канцероматозе брюшины. Показано, что платина попадает в системный кровоток и выводится с мочой. Максимум выведения приходится
Большой, Д.В., Максимовский, В.Е., Пыхтеева, Е.Г., Пыхтеева, Е.Д.   +3 more
core   +2 more sources

Small bowel obstruction and ovarian cancer: insights from a propensity-score matched study in patients with and without hyperthermic intraperitoneal chemotherapy after cytoreductive surgery

World Journal of Surgical Oncology
Background Small bowel obstruction (SBO) affects ~ 30% of ovarian cancer (OC) patients, leading to readmission, debilitating symptoms, and death within one year. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) effectively
Luis Felipe Falla-Zuniga, Armando Sardi, Mary Caitlin King, Felipe Lopez-Ramirez, Vladislav Kovalik, Sergei Iugai, Teresa Diaz-Montes, Vadim Gushchin   +7 more
doaj   +1 more source

Factors influencing hematological toxicity and adverse effects of perioperative hyperthermic intraperitoneal vs intraperitoneal chemotherapy in gastrointestinal cancer

Open Medicine
Intraperitoneal (IP) chemotherapy (IPC), including hyperthermic intraperitoneal chemotherapy (HIPEC), has emerged as a promising approach to control peritoneal metastases in gastrointestinal (GI) cancers. However, the safety profile and toxicity spectrum
Zhang Xue, Zheng Zhewen, Gao Hui, Yang Ziqi, Bai Jian   +4 more
doaj   +1 more source

`HIPEC´- Hyperthermic Intraperitoneal Chemotherapy. Evaluation of Intraperitoneal free cancer cells. [PDF]

, 2018
HIPEC is a great treatment option to cure GI and ovarian cancers at advanced stages. Also it improves survival rates. However there is a lack of knowledge about this method.
Romero Ramil, Lucia
core